- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 38/44 - Oxidoreductases (1)
Patent holdings for IPC class A61K 38/44
Total number of patents in this class: 1283
10-year publication summary
|
95
|
104
|
101
|
102
|
119
|
110
|
112
|
130
|
96
|
59
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Horizon Therapeutics USA, Inc. | 59 |
24 |
| Exoxemis, Inc. | 26 |
14 |
| Modernatx, Inc. | 1260 |
14 |
| Translate bio, Inc. | 414 |
14 |
| The Regents of the University of California | 19812 |
13 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3360 |
13 |
| Yale University | 2358 |
12 |
| President and Fellows of Harvard College | 5949 |
11 |
| Children's Medical Center Corporation | 1850 |
11 |
| CXL Ophthalmics, LLC | 18 |
11 |
| Synlogic Operating Company, Inc. | 114 |
11 |
| Matoke Holdings Limited | 32 |
10 |
| North Carolina State University | 1555 |
10 |
| Regeneron Pharmaceuticals, Inc. | 4223 |
10 |
| Selecta Biosciences, Inc. | 188 |
10 |
| The Trustees of the University of Pennsylvania | 4308 |
9 |
| Megmilk Snow Brand Co., Ltd. | 200 |
9 |
| Lpoxy Therapeutics, Inc | 21 |
9 |
| California Institute of Technology | 3967 |
8 |
| LTT Bio-Pharma Co., Ltd. | 45 |
8 |
| Other owners | 1052 |